Compare EKF Diagnostics Holdings Plc with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROE of 11.66%
- The company has been able to generate a Return on Equity (avg) of 11.66% signifying low profitability per unit of shareholders funds
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 10.04
3
With a growth in Net Sales of 1.03%, the company declared Very Positive results in Jun 25
4
With ROE of 9.53%, it has a fair valuation with a 1.57 Price to Book Value
5
Market Beating Performance
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
23.86%
0%
23.86%
6 Months
-1.61%
0%
-1.61%
1 Year
-15.86%
0%
-15.86%
2 Years
-22.54%
0%
-22.54%
3 Years
-34.83%
0%
-34.83%
4 Years
-67.41%
0%
-67.41%
5 Years
-47.33%
0%
-47.33%
EKF Diagnostics Holdings Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.16%
EBIT Growth (5y)
-5.55%
EBIT to Interest (avg)
10.04
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.82
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.35%
ROE (avg)
11.66%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.57
EV to EBIT
13.95
EV to EBITDA
8.42
EV to Capital Employed
1.74
EV to Sales
1.92
PEG Ratio
9.23
Dividend Yield
NA
ROCE (Latest)
12.48%
ROE (Latest)
9.53%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
50.20
52.60
-4.56%
Operating Profit (PBDIT) excl Other Income
11.20
10.20
9.80%
Interest
0.20
0.10
100.00%
Exceptional Items
-0.40
-2.80
85.71%
Consolidate Net Profit
6.60
2.70
144.44%
Operating Profit Margin (Excl OI)
128.70%
90.30%
3.84%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -4.56% vs -21.02% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 144.44% vs 128.12% in Dec 2023
About EKF Diagnostics Holdings Plc 
EKF Diagnostics Holdings Plc
Pharmaceuticals & Biotechnology
EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240.
Company Coordinates 
Company Details
Avon HSE, 19 Stanwell Road , PENARTH None : CF64 2EZ
Registrar Details






